Nomad Power Solutions NMAD
NASDAQ NMAD
$3.75 -0.03 (-0.79%)
At close: Nov 11, 2026 · 4:00 PM EST

Nomad Power Solutions (NMAD) Current Leases (2025 - 2026)

Updated

Analysis

Nomad Power Solutions (NMAD) Current Leases (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Nomad Power Solutions 58.28 Mn 35.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 595,418.00
Dec 31, 2025 595,418.00
API Access

Nomad Power Solutions Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=NMAD&period=max&api_key=YOUR_API_KEY